- €2.43bn
- €3.67bn
- €2.64bn
Synlab falls after Q3 profit miss
Brief: Synlab 9-Month Adjusted EBITDA At EUR 663 Mln
Brief: SYNLAB And Microba Expand Strategic Agreement On Advanced Gut Microbiome Test MyBIOME
Brief: Synlab Announces Resolution Of Management Board Of Company, With Approval Of Supervisory Board Of Company, For Repurchase Of Up To 1,860,647 Shares In Company
Europe Research Roundup: BKW AG, Darktrace, Synlab AG
Berenberg starts Synlab with 'buy' on solid organic growth, strong market position
Europe Research Roundup: Boliden AB, H&M, Uniper SE
Europe Research Roundup: Carrefour, Kingspan Group, Molecular Partners AG
Brief: Synlab H1 Adjusted EBITDA At EUR 528 Mln
Brief: Synlab H1 2022 Reported Revenue Was Down 4% To EUR 1,851 Mln
Europe Research Roundup: Allianz, EDF, Kering
German stocks - Factors to watch on July 11
German stocks - Factors to watch on May 17
Europe Research Roundup: Coca Cola HBC, Genmab A/S, TotalEnergies SE
Brief: Synlab Q1 Adjusted EBITDA At EUR 357 Mln
Europe Research Roundup: Admiral, Mercedes-Benz Group, Ubisoft
Brief: SYNLAB And OncoDNA To Provide Comprehensive Biomarker Testing For Cancer Therapy Selection
Brief: Synlab Approves Share Buy-Back To Service Participation Programs
Europe Research Roundup: Buzzi Unicem, Diageo, Heidelbergcement